![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 8, 6834-6839, February 20, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Synuclein/Synphilin-1 Interaction and Inclusion Body Formation*



¶
||
**







¶¶
From the
Genetic Pharmacology Unit, NINDS, National Institutes of Health, Bethesda, Maryland 20824, 
Department of Neurology, University of Medicine and Dentistry-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, and
Laboratory of Medical Genetics, Ajou University School of Medicine, Ajou University, Wonchon-Dong, Paldal-Gu, Suwon 442-721, Korea
-Synuclein is a phosphoprotein that accumulates as a major component of Lewy bodies in the brains of patients with Parkinson disease. Synphilin-1, which is also present in Lewy bodies, binds with
-synuclein and forms cytoplasmic inclusions in transfected cells. Yet the molecular determinants of this protein-protein interaction are unknown. Here we report that casein kinase II (CKII) phosphorylates synphilin-1 and that the
subunit of this enzyme complex binds to synphilin-1. Additionally, both CKII
and
subunits are present within cytoplasmic inclusions in cells that overexpress synphilin-1. Notably, the interaction between synphilin-1 and
-synuclein is markedly dependent on phosphorylation. Inhibition of CKII activity by 5,6-dichloro-1-
-D-ribofuranosylbenzimidazole blocks the binding between these two proteins and significantly reduces the percentage of cells that contain eosinophilic cytoplasmic inclusions. Mutation of the major CKII phosphorylation site in
-synuclein (S129A) has no significant impact on the binding between
-synuclein and synphilin-1 or on the formation of synphilin-1/
-synuclein-positive inclusions. These data suggest that the CKII-mediated phosphorylation of synphilin-1 rather than that of
-synuclein is critical in modulating their tendency to aggregate into inclusions. These observations collectively indicate that a ubiquitous post-translational modification such as phosphorylation can regulate inclusion body formation in the context of
-synuclein and synphilin-1 interaction.
Received for publication, November 21, 2003
* This work was supported in part by Korea Research Foundation Grant KRF-2001-005-F20002 (to G. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Present address: Dept. of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 440-746, Korea.
|| Present address: Dept. of Pharmacology, Inje University College of Medicine, 633-165, Kaekum-dong, Jin-ku, Busan 614-735, Korea.
** Present address: Dept. of Parasitology, College of Medicine, Wonkwang University, Jeonbuk, Korea.

Present address: Dept. of Bioscience and Biotechnology, Silla University, Kwaebop-dong, Sasang-gu, Busan 617-736, Korea.
¶¶ To whom correspondence should be addressed: William Dow Lovett Professor of Neurology, Department of Neurology, UMDNJ/Robert Wood Johnson Medical School, 683 Hoes Lane, Rm. 180, Piscataway, NJ 08854. Tel.: 732-235-4772; Fax: 732-235-4773; E-mail: mouradian{at}umdnj.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. E. Paleologou, A. W. Schmid, C. C. Rospigliosi, H.-Y. Kim, G. R. Lamberto, R. A. Fredenburg, P. T. Lansbury Jr., C. O. Fernandez, D. Eliezer, M. Zweckstetter, et al. Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of {alpha}-Synuclein J. Biol. Chem., June 13, 2008; 283(24): 16895 - 16905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ahmad, S. Attoub, M. N. Singh, F. L. Martin, and O. M. A. El-Agnaf {gamma}-Synuclein and the progression of cancer FASEB J, November 1, 2007; 21(13): 3419 - 3430. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ryo, T. Togo, T. Nakai, A. Hirai, M. Nishi, A. Yamaguchi, K. Suzuki, Y. Hirayasu, H. Kobayashi, K. Perrem, et al. Prolyl-isomerase Pin1 Accumulates in Lewy Bodies of Parkinson Disease and Facilitates Formation of {alpha}-Synuclein Inclusions J. Biol. Chem., February 17, 2006; 281(7): 4117 - 4125. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Avraham, R. Szargel, A. Eyal, R. Rott, and S. Engelender Glycogen Synthase Kinase 3beta Modulates Synphilin-1 Ubiquitylation and Cellular Inclusion Formation by SIAH: IMPLICATIONS FOR PROTEASOMAL FUNCTION AND LEWY BODY FORMATION J. Biol. Chem., December 30, 2005; 280(52): 42877 - 42886. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Smith, R. L. Margolis, X. Li, J. C. Troncoso, M. K. Lee, V. L. Dawson, T. M. Dawson, T. Iwatsubo, and C. A. Ross {alpha}-Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells J. Neurosci., June 8, 2005; 25(23): 5544 - 5552. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |